lobbying_activities: 2865289

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2865289	c3994e5a-ca36-4017-8a4a-c5870053eb40	Q3	DESIMONE CONSULTING, LLC	400931695	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)	2022	third_quarter	PHA	Issues related to patient access and pricing; Issues related to policy changes to Medicare Part D; Issues related to PBM reform; PDUFA Reauthorization, H.R.7667, Food and Drug Amendments of 2022, S.4348, FDASLA Act of 2022; FY2022 Budget Reconciliation (H.R.5376); H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2022-10-14T12:52:26-04:00